Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep 20:2:7.
doi: 10.1186/1743-8454-2-7.

Cerebrospinal fluid may mediate CNS ischemic injury

Affiliations

Cerebrospinal fluid may mediate CNS ischemic injury

Yanming F Wang et al. Cerebrospinal Fluid Res. .

Abstract

Background: The central nervous system (CNS) is extremely vulnerable to ischemic injury. The details underlying this susceptibility are not completely understood. Since the CNS is surrounded by cerebrospinal fluid (CSF) that contains a low concentration of plasma protein, we examined the effect of changing the CSF in the evolution of CNS injury during ischemic insult.

Methods: Lumbar spinal cord ischemia was induced in rabbits by cross-clamping the descending abdominal aorta for 1 h, 2 h or 3 h followed by 7 d of reperfusion. Prior to ischemia, rabbits were subjected to the following procedures; 1) CSF depletion, 2) CSF replenishment at 0 mmHg intracranial pressure (ICP), and 3) replacement of CSF with 8% albumin- or 1% gelatin-modified artificial CSF, respectively. Motor function of the hind limbs and histopathological changes of the spinal cord were scored. Post-ischemic microcirculation of the spinal cord was visualized by fluorescein isothiocyanate (FITC) albumin.

Results: The severity of histopathological damage paralleled the neurological deficit scores. Paraplegia and associated histopathological changes were accompanied by a clear post-ischemic deficit in blood perfusion. Spinal cord ischemia for 1 h resulted in permanent paraplegia in the control group. Depletion of the CSF significantly prevented paraplegia. CSF replenishment with the ICP reduced to 0 mmHg, did not prevent paraplegia. Replacement of CSF with albumin- or gelatin-modified artificial CSF prevented paraplegia in rabbits even when the ICP was maintained at 10-15 mmHg.

Conclusion: We conclude that the presence of normal CSF may contribute to the vulnerability of the spinal cord to ischemic injury. Depletion of the CSF or replacement of the CSF with an albumin- or gelatin-modified artificial CSF can be neuroprotective.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of CSF removal and replacement of CSF with albumin- and gelatine-modified artificial CSF on rabbit spinal cord ischemia. Group 1 (closed circles). 1 h ischemia; prior treatment: none; ICP: 10–15 mmHg. Group 2 (open circles). 1 h ischemia; prior treatment: CSF depleted; ICP: 0 mmHg. Group 3 (closed triangles). 1 h ischemia; prior treatment: CSF replenished; ICP: 0 mmHg. Group 4 (open triangles). 1 h ischemia; prior treatment: 8% albumin in artificial CSF; ICP: 10–15 mmHg. Group 5 (closed squares). 1 h ischemia:; prior treatment: 1% gelatin in artificial CSF; ICP: 10–15 mmHg. Group 6 (open squares). 2 h ischemia; prior treatment: CSF depleted; ICP: 0 mmHg. Group 7 (closed diamonds). 3 h ischemia; prior treatment: CSF depleted; ICP: 0 mmHg. A. Neurological deficit (Tarlov score) determined at 7 d after spinal cord ischemia. Group 1 vs. groups 2, 4, 5 and 6; Group 3 vs group 2, 4 and 5; Group 7 vs. group 2 and 5 are significantly different when analyzed by Kruskal Wallis ANOVA followed by Dunn's test (p < 0.05). B. Histopathological score determined at 7 d after spinal cord ischemia by H&E staining. Groups 1, 3 and 7 vs. Groups 2, 4, 5 and 6 were significantly different analyzed by Kruskal Wallis ANOVA followed by Dunn's test (p < 0.05).
Figure 2
Figure 2
Transverse sections of rabbit lumbar spinal cord after 1 h ischemia (H&E stain). A. Histopathological score 3, from a rabbit of Group 1. Severe necrosis destroys the entire structure of grey matter indiscriminately. B. Histopathological score 1, from a rabbit of Group 2. No apparent spinal cord damage, the grey matter is well preserved. C. Higher magnification of B showing normal morphology of grey matter and neurons. D. Histopathological score 2, from a rabbit of Group 3. The grey matter is lightly stained with many vacuolations of the neuropil. E. Higher magnification of D. Marked vacuolations of the neuropil in the grey matter, and some neurons are triangular with darkly stained shrunken nuclei (arrow).
Figure 3
Figure 3
Transverse sections of rabbit lumbar spinal cord to show the microcirculation after 1 h of ischemia and 23 h reperfusion, revealed by FITC-albumin. A. No CSF removed (Group 1) – the spinal cord demonstrates extremely faint fluorescein signal with absence of capillary filling in both grey matter and white matter, indicating a 'no-reflow' phenomenon. B. Depletion of the CSF (Group 2) – spinal cord section demonstrates intensive fluorescein signals, which are much stronger in grey matter than in white matter, indicating good blood perfusion. C. Replenishment of the CSF (Group 3) – grey matter demonstrates faint fluorescein signal similar to white matter, indicating a marked blood perfusion deficit, i.e. 'low-reflow' phenomenon. D. Albumin-modified artificial CSF replacement (Group 4), and E. Gelatin-modified artificial CSF replacement (Group 5) – capillary filling in both grey matter and white matter are clearly demonstrated by good fluorescein signal, albeit slightly less than that of Group 2, indicating some preservation of blood perfusion.
Figure 4
Figure 4
Overview of mechanisms underlying the CNS vulnerability to ischemia. Blood brain barrier and Blood-CSF barrier determine the low protein concentration in the cerebrospinal fluid and the interstitial fluid. A large amount of free fluid causes the CNS cells to consume more energy to maintain normal intracellular environment. The positive intracranial pressure facilitates the edema formation. Edema results in 'no-reflow' phenomenon.

Similar articles

Cited by

References

    1. Dirnagl U, Iadecola C, Moskowiz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391–397. doi: 10.1016/S0166-2236(99)01401-0. - DOI - PubMed
    1. Fisher M, Schaebitz W. An overview of acute stroke therapy. Past, present, and future. Arch Intern Med. 2000;160:3196–3206. doi: 10.1001/archinte.160.21.3196. - DOI - PubMed
    1. De Keyser J, Sulter G, Luiten PG. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 1999;22:535–540. doi: 10.1016/S0166-2236(99)01463-0. - DOI - PubMed
    1. Guyton AC, Hall JE. Textbook of Medical Physiology. Philadelphia: WB Saunders Company; 1998.
    1. Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience. 2004;129:957–970. doi: 10.1016/j.neuroscience.2004.07.003. - DOI - PMC - PubMed

LinkOut - more resources